Global Anti-Obesity Drug Industry 2016 Market Research Report

May 2016 | 159 pages | ID: GFAAFC0CA67EN
QYResearch

Abstracts

The Global Anti-Obesity Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Anti-Obesity Drug industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Anti-Obesity Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Anti-Obesity Drug industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

1 INDUSTRY OVERVIEW OF ANTI-OBESITY DRUG

1.1 Definition and Specifications of Anti-Obesity Drug
  1.1.1 Definition of Anti-Obesity Drug
  1.1.2 Specifications of Anti-Obesity Drug
1.2 Classification of Anti-Obesity Drug
1.3 Applications of Anti-Obesity Drug
1.4 Industry Chain Structure of Anti-Obesity Drug
1.5 Industry Overview and Major Regions Status of Anti-Obesity Drug
  1.5.1 Industry Overview of Anti-Obesity Drug
  1.5.2 Global Major Regions Status of Anti-Obesity Drug
1.6 Industry Policy Analysis of Anti-Obesity Drug
1.7 Industry News Analysis of Anti-Obesity Drug

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTI-OBESITY DRUG

2.1 Raw Material Suppliers and Price Analysis of Anti-Obesity Drug
2.2 Equipment Suppliers and Price Analysis of Anti-Obesity Drug
2.3 Labor Cost Analysis of Anti-Obesity Drug
2.4 Other Costs Analysis of Anti-Obesity Drug
2.5 Manufacturing Cost Structure Analysis of Anti-Obesity Drug
2.6 Manufacturing Process Analysis of Anti-Obesity Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTI-OBESITY DRUG

3.1 Capacity and Commercial Production Date of Global Anti-Obesity Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Anti-Obesity Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Anti-Obesity Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Anti-Obesity Drug Major Manufacturers in 2015

4 CAPACITY, PRODUCTION AND REVENUE ANALYSIS OF ANTI-OBESITY DRUG BY REGIONS, TYPES AND MANUFACTURERS

4.1 Global Capacity, Production and Revenue of Anti-Obesity Drug by Regions 2011-2016
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Anti-Obesity Drug 2011-2016
4.3 Global Capacity, Production and Revenue of Anti-Obesity Drug by Types 2011-2016
4.4 Global Capacity, Production and Revenue of Anti-Obesity Drug by Manufacturers 2011-2016

5 PRICE, COST, GROSS AND GROSS MARGIN ANALYSIS OF ANTI-OBESITY DRUG BY REGIONS, TYPES AND MANUFACTURERS

5.1 Price, Cost, Gross and Gross Margin Analysis of Anti-Obesity Drug by Regions 2011-2016
5.2 Price, Cost, Gross and Gross Margin Analysis of Anti-Obesity Drug by Types 2011-2016
5.3 Price, Cost, Gross and Gross Margin Analysis of Anti-Obesity Drug by Manufacturers 2011-2016

6 CONSUMPTION VOLUME, CONSUMPTION VALUE AND SALE PRICE ANALYSIS OF ANTI-OBESITY DRUG BY REGIONS, TYPES AND APPLICATIONS

6.1 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Regions 2011-2016
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Anti-Obesity Drug 2011-2016
6.3 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Types 2011-2016
6.4 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Applications 2011-2016
6.5 Sale Price of Anti-Obesity Drug by Regions 2011-2016
6.6 Sale Price of Anti-Obesity Drug by Types 2011-2016
6.7 Sale Price of Anti-Obesity Drug by Applications 2011-2016
6.8 Market Share Analysis of Anti-Obesity Drug by Different Sale Price Levels

7 SUPPLY, IMPORT, EXPORT AND CONSUMPTION ANALYSIS OF ANTI-OBESITY DRUG

7.1 Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016
7.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016
7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016
7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016

8 MAJOR MANUFACTURERS ANALYSIS OF ANTI-OBESITY DRUG

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.1.4 Contact Information
8.2 Merck
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.2.4 Contact Information
8.3 F. Hoffmann-La Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.3.4 Contact Information
8.4 GlaxoSmithKline
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.4.4 Contact Information
8.5 AstraZeneca
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.5.4 Contact Information
8.6 Boehringer Ingelheim
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.6.4 Contact Information
8.7 Novo Nordisk
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.7.4 Contact Information
8.8 Eisai
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.8.4 Contact Information
8.9 Norgine
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.9.4 Contact Information
8.10 Arena Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
  8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.10.4 Contact Information
8.11 Orexigen Therapeutics
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
  8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.11.4 Contact Information
8.12 Vivus
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
  8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.12.4 Contact Information
8.13 Alizyme
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
  8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.13.4 Contact Information
8.14 Rhythm Pharmaceuticals
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
  8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.14.4 Contact Information
8.15 Shionogi
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
  8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.15.4 Contact Information
8.16 Zafgan
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
  8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
  8.16.4 Contact Information

9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF ANTI-OBESITY DRUG

9.1 Marketing Channels Status of Anti-Obesity Drug
9.2 Traders or Distributors with Contact Information of Anti-Obesity Drug by Regions
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Anti-Obesity Drug
9.4 Regional Import, Export and Trade Analysis of Anti-Obesity Drug

10 INDUSTRY CHAIN ANALYSIS OF ANTI-OBESITY DRUG

10.1 Upstream Major Raw Materials Suppliers Analysis of Anti-Obesity Drug
  10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Anti-Obesity Drug
  10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Anti-Obesity Drug by Regions
10.2 Upstream Major Equipment Suppliers Analysis of Anti-Obesity Drug
  10.2.1 Major Equipment Suppliers with Contact Information Analysis of Anti-Obesity Drug
  10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Anti-Obesity Drug by Regions
10.3 Downstream Major Consumers Analysis of Anti-Obesity Drug
  10.3.1 Major Consumers with Contact Information Analysis of Anti-Obesity Drug
  10.3.2 Major Consumers with Consumption Volume Analysis of Anti-Obesity Drug by Regions
10.4 Supply Chain Relationship Analysis of Anti-Obesity Drug

11 DEVELOPMENT TREND OF ANALYSIS OF ANTI-OBESITY DRUG

11.1 Capacity, Production and Revenue Forecast of Anti-Obesity Drug by Regions and Types
  11.1.1 Global Capacity, Production and Revenue of Anti-Obesity Drug by Regions 2016-2021
  11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Anti-Obesity Drug 2016-2021
  11.1.3 Global Capacity, Production and Revenue of Anti-Obesity Drug by Types 2016-2021
11.2 Consumption Volume and Consumption Value Forecast of Anti-Obesity Drug by Regions, Types and Applications
  11.2.1 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Regions 2016-2021
  11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Anti-Obesity Drug 2016-2021
  11.2.3 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Types 2016-2021
  11.2.4 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Applications 2016-2021
11.3 Supply, Import, Export and Consumption Forecast of Anti-Obesity Drug
  11.3.1 Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021
  11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021
  11.3.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021
  11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021
  11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021
  11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF ANTI-OBESITY DRUG

12.1 New Project SWOT Analysis of Anti-Obesity Drug
12.2 New Project Investment Feasibility Analysis of Anti-Obesity Drug

13 CONCLUSION OF THE GLOBAL ANTI-OBESITY DRUG INDUSTRY 2016 MARKET RESEARCH REPORT

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-Obesity Drug
Table Product Specifications of Anti-Obesity Drug
Table Classification of Anti-Obesity Drug
Figure Global Production Market Share of Anti-Obesity Drug by Types in 2015
Table Applications of Anti-Obesity Drug
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2015
Figure Industry Chain Structure of Anti-Obesity Drug
Table Global Anti-Obesity Drug Major Manufacturers
Table Global Major Regions Anti-Obesity Drug Development Status
Table Industry Policy of Anti-Obesity Drug
Table Industry News List of Anti-Obesity Drug
Table Raw Material Suppliers and Price Analysis
Table Equipment Suppliers and Price Analysis
Table Manufacturing Cost Structure Analysis of Anti-Obesity Drug in 2015
Figure Manufacturing Process Analysis of Anti-Obesity Drug
Table Capacity (K Doses) and Commercial Production Date of Global Anti-Obesity Drug Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Anti-Obesity Drug Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Anti-Obesity Drug Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Anti-Obesity Drug Major Manufacturers in 2015
Table Global Capacity (K Doses) of Anti-Obesity Drug by Regions 2011-2016
Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2011
Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2015
Table Global Production (K Doses) of Anti-Obesity Drug by Regions 2011-2016
Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2011
Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2015
Table Global Revenue (M USD) of Anti-Obesity Drug by Regions 2011-2016
Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2011
Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2015
Figure Global Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure Global Capacity Utilization Rate of Anti-Obesity Drug 2011-2016
Figure Global Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure United States Capacity Utilization Rate of Anti-Obesity Drug 2011-2016
Figure United States Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure EU Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure EU Capacity Utilization Rate of Anti-Obesity Drug 2011-2016
Figure EU Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure China Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure China Capacity Utilization Rate of Anti-Obesity Drug 2011-2016
Figure China Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure Japan Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure Japan Capacity Utilization Rate of Anti-Obesity Drug 2011-2016
Figure Japan Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Table Global Capacity (K Doses) of Anti-Obesity Drug by Types 2011-2016
Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2011
Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2015
Table Global Production (K Doses) of Anti-Obesity Drug by Types 2011-2016
Figure Global Production Market Share of Anti-Obesity Drug by Types in 2011
Figure Global Production Market Share of Anti-Obesity Drug by Types in 2015
Table Global Revenue (M USD) of Anti-Obesity Drug by Types 2011-2016
Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2011
Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2015
Table Global and Major Manufacturers Capacity (K Doses) of Anti-Obesity Drug 2011-2016
Table Global Capacity Market Share of Anti-Obesity Drug Major Manufacturers 2011-2016
Figure Global Capacity Market Share of Anti-Obesity Drug Major Manufacturers in 2011
Figure Global Capacity Market Share of Anti-Obesity Drug Major Manufacturers in 2015
Table Global and Major Manufacturers Production (K Doses) of Anti-Obesity Drug 2011-2016
Table Global Production Market Share of Anti-Obesity Drug Major Manufacturers 2011-2016
Figure Global Production Market Share of Anti-Obesity Drug Major Manufacturers in 2011
Figure Global Production Market Share of Anti-Obesity Drug Major Manufacturers in 2015
Table Global and Major Manufacturers Revenue (M USD) of Anti-Obesity Drug 2011-2016
Table Global Revenue Market Share of Anti-Obesity Drug Major Manufacturers 2011-2016
Figure Global Revenue Market Share of Anti-Obesity Drug Major Manufacturers in 2011
Figure Global Revenue Market Share of Anti-Obesity Drug Major Manufacturers in 2015
Table Price (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016
Figure Price (USD/Dose) of Anti-Obesity Drug by Regions in 2015
Table Cost (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016
Figure Cost (USD/Dose) of Anti-Obesity Drug by Regions in 2015
Table Gross (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016
Figure Gross (USD/Dose) of Anti-Obesity Drug by Regions in 2015
Table Gross Margin of Anti-Obesity Drug by Regions 2011-2016
Figure Gross Margin of Anti-Obesity Drug by Regions in 2015
Table Price (USD/Dose) of Anti-Obesity Drug by Types 2011-2016
Figure Price (USD/Dose) of Anti-Obesity Drug by Types in 2015
Table Cost (USD/Dose) of Anti-Obesity Drug by Types 2011-2016
Figure Cost (USD/Dose) of Anti-Obesity Drug by Types in 2015
Table Gross (USD/Dose) of Anti-Obesity Drug by Types 2011-2016
Figure Gross (USD/Dose) of Anti-Obesity Drug by Types in 2015
Table Gross Margin of Anti-Obesity Drug by Types 2011-2016
Figure Gross Margin of Anti-Obesity Drug by Types in 2015
Table Price (USD/Dose) of Anti-Obesity Drug by Manufacturers 2011-2016
Figure Price (USD/Dose) of Anti-Obesity Drug by Manufacturers in 2015
Table Cost (USD/Dose) of Anti-Obesity Drug by Manufacturers 2011-2016
Figure Cost (USD/Dose) of Anti-Obesity Drug by Manufacturers in 2015
Table Gross (USD/Dose) of Anti-Obesity Drug by Manufacturers 2011-2016
Figure Gross (USD/Dose) of Anti-Obesity Drug by Manufacturers in 2015
Table Gross Margin of Anti-Obesity Drug by Manufacturers 2011-2016
Figure Gross Margin of Anti-Obesity Drug by Manufacturers in 2015
Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Regions 2011-2016
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2011
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2015
Table Global Consumption Value (M USD) of Anti-Obesity Drug by Regions 2011-2016
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2011
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2015
Figure Global Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure Global Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure United States Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure United States Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure EU Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure EU Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure China Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure China Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure Japan Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016
Figure Japan Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016
Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Types 2011-2016
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2011
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2015
Table Global Consumption Value (M USD) of Anti-Obesity Drug by Types 2011-2016
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2011
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2015
Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Applications 2011-2016
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2011
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2015
Table Global Consumption Value (M USD) of Anti-Obesity Drug by Applications 2011-2016
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2011
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2015
Table Sale Price (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016
Figure Sale Price (USD/Dose) of Anti-Obesity Drug by Regions in 2015
Table Sale Price (USD/Dose) of Anti-Obesity Drug by Types 2011-2016
Figure Sale Price (USD/Dose) of Anti-Obesity Drug by Types in 2015
Table Sale Price (USD/Dose) of Anti-Obesity Drug by Applications 2011-2016
Figure Sale Price (USD/Dose) of Anti-Obesity Drug by Applications in 2015
Table Market Share of Anti-Obesity Drug by Different Sale Price Levels
Table Global Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses)
Table United States Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses)
Table EU Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses)
Table China Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses)
Table Japan Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses)
Table Global Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016
Table United States Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016
Table United States Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses)
Table EU Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016
Table EU Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses)
Table China Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016
Table China Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses)
Table Japan Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016
Table Japan Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses)
Table Pfizer Information List
Figure Anti-Obesity Drug Picture and Specifications of Pfizer
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Pfizer 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Pfizer 2011-2016
Table Merck Information List
Figure Anti-Obesity Drug Picture and Specifications of Merck
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Merck 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Merck 2011-2016
Table F. Hoffmann-La Roche Information List
Figure Anti-Obesity Drug Picture and Specifications of F. Hoffmann-La Roche
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of F. Hoffmann-La Roche 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of F. Hoffmann-La Roche 2011-2016
Table GlaxoSmithKline Information List
Figure Anti-Obesity Drug Picture and Specifications of GlaxoSmithKline
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of GlaxoSmithKline 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of GlaxoSmithKline 2011-2016
Table AstraZeneca Information List
Figure Anti-Obesity Drug Picture and Specifications of AstraZeneca
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of AstraZeneca 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of AstraZeneca 2011-2016
Table Boehringer Ingelheim Information List
Figure Anti-Obesity Drug Picture and Specifications of Boehringer Ingelheim
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Boehringer Ingelheim 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Boehringer Ingelheim 2011-2016
Table Novo Nordisk Information List
Figure Anti-Obesity Drug Picture and Specifications of Novo Nordisk
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Novo Nordisk 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Novo Nordisk 2011-2016
Table Eisai Information List
Figure Anti-Obesity Drug Picture and Specifications of Eisai
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eisai 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Eisai 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Eisai 2011-2016
Table Norgine Information List
Figure Anti-Obesity Drug Picture and Specifications of Norgine
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Norgine 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Norgine 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Norgine 2011-2016
Table Arena Pharmaceuticals Information List
Figure Anti-Obesity Drug Picture and Specifications of Arena Pharmaceuticals
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Arena Pharmaceuticals 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Arena Pharmaceuticals 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Arena Pharmaceuticals 2011-2016
Table Orexigen Therapeutics Information List
Figure Anti-Obesity Drug Picture and Specifications of Orexigen Therapeutics
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Orexigen Therapeutics 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Orexigen Therapeutics 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Orexigen Therapeutics 2011-2016
Table Vivus Information List
Figure Anti-Obesity Drug Picture and Specifications of Vivus
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Vivus 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Vivus 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Vivus 2011-2016
Table Alizyme Information List
Figure Anti-Obesity Drug Picture and Specifications of Alizyme
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alizyme 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Alizyme 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Alizyme 2011-2016
Table Rhythm Pharmaceuticals Information List
Figure Anti-Obesity Drug Picture and Specifications of Rhythm Pharmaceuticals
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Rhythm Pharmaceuticals 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Rhythm Pharmaceuticals 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Rhythm Pharmaceuticals 2011-2016
Table Shionogi Information List
Figure Anti-Obesity Drug Picture and Specifications of Shionogi
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Shionogi 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Shionogi 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Shionogi 2011-2016
Table Zafgan Information List
Figure Anti-Obesity Drug Picture and Specifications of Zafgan
Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Zafgan 2011-2016
Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Zafgan 2011-2016
Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Zafgan 2011-2016
Figure Marketing Channels of Anti-Obesity Drug
Table Traders or Distributors with Contact Information of Anti-Obesity Drug by Regions
Table Ex-work Price, Channel Price and End Buyer Price of Anti-Obesity Drug (USD/Dose)
Table Regional Import, Export, and Trade of Anti-Obesity Drug (K Doses)
Table Flow of International Trade in 2015
Table Major Raw Materials Suppliers with Contact Information of Anti-Obesity Drug
Table Major Raw Materials Suppliers with Supply Volume of Anti-Obesity Drug by Regions
Table Major Equipment Suppliers with Contact Information of Anti-Obesity Drug
Table Major Equipment Suppliers with Product Pictures of Anti-Obesity Drug by Regions
Table Major Consumers with Contact Information of Anti-Obesity Drug
Table Major Consumers with Consumption Volume of Anti-Obesity Drug by Regions
Figure Supply Chain Relationship Analysis of Anti-Obesity Drug
Table Global Capacity (K Doses) of Anti-Obesity Drug by Regions 2016-2021
Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2016
Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2021
Table Global Production (K Doses) of Anti-Obesity Drug by Regions 2016-2021
Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2016
Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2021
Table Global Revenue (M USD) of Anti-Obesity Drug by Regions 2016-2021
Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2016
Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2021
Figure Global Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure Global Capacity Utilization Rate of Anti-Obesity Drug 2016-2021
Figure Global Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure United States Capacity Utilization Rate of Anti-Obesity Drug 2016-2021
Figure United States Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure EU Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure EU Capacity Utilization Rate of Anti-Obesity Drug 2016-2021
Figure EU Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure China Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure China Capacity Utilization Rate of Anti-Obesity Drug 2016-2021
Figure China Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure Japan Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure Japan Capacity Utilization Rate of Anti-Obesity Drug 2016-2021
Figure Japan Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Table Global Capacity (K Doses) of Anti-Obesity Drug by Types 2016-2021
Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2016
Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2021
Table Global Production (K Doses) of Anti-Obesity Drug by Types 2016-2021
Figure Global Production Market Share of Anti-Obesity Drug by Types in 2016
Figure Global Production Market Share of Anti-Obesity Drug by Types in 2021
Table Global Revenue (M USD) of Anti-Obesity Drug by Types 2016-2021
Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2016
Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2021
Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Regions 2016-2021
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2016
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2021
Table Global Consumption Value (M USD) of Anti-Obesity Drug by Regions 2016-2021
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2016
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2021
Figure Global Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure Global Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure United States Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure United States Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure EU Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure EU Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure China Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure China Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure Japan Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021
Figure Japan Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021
Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Types 2016-2021
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2016
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2021
Table Global Consumption Value (M USD) of Anti-Obesity Drug by Types 2016-2021
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2016
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2021
Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Applications 2016-2021
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2016
Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2021
Table Global Consumption Value (M USD) of Anti-Obesity Drug by Applications 2016-2021
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2016
Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2021
Table Global Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses)
Table United States Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses)
Table EU Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses)
Table China Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses)
Table Japan Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses)
Table Global Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021
Table United States Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021
Table United States Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses)
Table EU Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021
Table EU Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses)
Table China Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021
Table China Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses)
Table Japan Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021
Table Japan Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses)
Table New Project SWOT Analysis of Anti-Obesity Drug
Table New Project Investment Feasibility Analysis of Anti-Obesity Drug
Table Part of Interviewees Record List